Completed PHASE1 INTERVENTIONAL 2-arm NCT02852681

Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers

A Study to Characterize the Effect of Food on the Bioavailability of 15 mg Estetrol (E4)/3 mg Drospirenone (DRSP) Tablets in Healthy Female Volunteers

Sponsor: Estetra

Conditions Contraception

Interventions 15 mg E4/3 mg DRSP

Updated 5 times since 2017 Last updated: Jul 28, 2016 Started: Aug 31, 2015 Primary completion: Oct 31, 2015 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02852681, this PHASE1 trial focuses on Contraception and remains completed. Sponsored by Estetra, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Estetra

Data source: Estetra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.